These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16940181)

  • 41. An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells.
    Baran-Gale J; Purvis JE; Sethupathy P
    RNA; 2016 Oct; 22(10):1592-603. PubMed ID: 27539783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
    Azorsa DO; Cunliffe HE; Meltzer PS
    Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-199b-5p targets HER2 in breast cancer cells.
    Fang C; Zhao Y; Guo B
    J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor.
    Font de Mora J; Brown M
    Mol Cell Biol; 2000 Jul; 20(14):5041-7. PubMed ID: 10866661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3.
    Mussi P; Yu C; O'Malley BW; Xu J
    Mol Endocrinol; 2006 Dec; 20(12):3105-19. PubMed ID: 16916939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of AIB1 expression in human breast cancer.
    Iwase H; Omoto Y; Toyama T; Yamashita H; Hara Y; Sugiura H; Zhang Z
    Breast Cancer Res Treat; 2003 Aug; 80(3):339-45. PubMed ID: 14503806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplified in breast cancer 1 expression in breast cancer.
    Thorat MA; Turbin D; Morimiya A; Leung S; Zhang Q; Jeng MH; Huntsman DG; Nakshatri H; Badve S
    Histopathology; 2008 Dec; 53(6):634-41. PubMed ID: 19102007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.
    Amazit L; Pasini L; Szafran AT; Berno V; Wu RC; Mielke M; Jones ED; Mancini MG; Hinojos CA; O'Malley BW; Mancini MA
    Mol Cell Biol; 2007 Oct; 27(19):6913-32. PubMed ID: 17646391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-129-5p suppresses breast cancer proliferation by targeting CBX4.
    Meng R; Fang J; Yu Y; Hou LK; Chi JR; Chen AX; Zhao Y; Cao XC
    Neoplasma; 2018; 65(4):572-578. PubMed ID: 29940764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
    Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
    Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-500a-5p regulates oxidative stress response genes in breast cancer and predicts cancer survival.
    Degli Esposti D; Aushev VN; Lee E; Cros MP; Zhu J; Herceg Z; Chen J; Hernandez-Vargas H
    Sci Rep; 2017 Nov; 7(1):15966. PubMed ID: 29162888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.
    Wong LJ; Dai P; Lu JF; Lou MA; Clarke R; Nazarov V
    BMC Cancer; 2006 May; 6():111. PubMed ID: 16670003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer.
    Sharifi M; Moridnia A
    Cancer Gene Ther; 2017 Feb; 24(2):75-82. PubMed ID: 28084318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway.
    Li HC; Chen YF; Feng W; Cai H; Mei Y; Jiang YM; Chen T; Xu K; Feng DX
    Gene; 2017 Mar; 603():1-8. PubMed ID: 27916718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner.
    Ma N; Wang X; Qiao Y; Li F; Hui Y; Zou C; Jin J; Lv G; Peng Y; Wang L; Huang H; Zhou L; Zheng X; Gao X
    Mol Cell Endocrinol; 2011 Feb; 333(1):96-101. PubMed ID: 21146586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.